当前位置:首页 - 行情中心 - 美康生物(300439) - 财务分析 - 现金流量表

美康生物

(300439)

  

流通市值:29.32亿  总市值:38.55亿
流通股本:2.92亿   总股本:3.84亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,303,354,569.38860,677,123.23387,037,100.61,921,359,967.36
  收到的税费返还3,627,097.1368,961.4668,944.038,271,688.91
  收到其他与经营活动有关的现金88,163,317.5379,610,740.6428,609,126.6560,789,903.83
  经营活动现金流入小计1,395,144,984.04940,356,825.33415,715,171.281,990,421,560.1
  购买商品、接受劳务支付的现金713,398,121.97473,111,941.7236,409,559.98867,378,939.67
  支付给职工以及为职工支付的现金288,575,270.61208,789,868.37134,568,255.37385,869,242.06
  支付的各项税费78,669,870.7855,689,250.9228,519,886.73106,535,732.6
  支付其他与经营活动有关的现金169,523,975.73106,479,848.7562,476,657.79232,825,498.12
  经营活动现金流出小计1,250,167,239.09844,070,909.74461,974,359.871,592,609,412.45
  经营活动产生的现金流量净额144,977,744.9596,285,915.59-46,259,188.59397,812,147.65
二、投资活动产生的现金流量:
  收回投资收到的现金703,000,000516,000,000173,000,000934,710,000
  取得投资收益收到的现金19,478,222.719,211,494.74384,460.563,990,185.53
  处置固定资产、无形资产和其他长期资产收回的现金净额101,041.5575,594.3493,071.534,321,144.6
  处置子公司及其他营业单位收到的现金净额584,944.25-023,970,733.97
  收到的其他与投资活动有关的现金0-015,015,530
  投资活动现金流入小计723,164,208.45535,787,089.08173,477,532.061,012,007,594.1
  购建固定资产、无形资产和其他长期资产支付的现金76,382,180.8564,682,728.2744,143,555.31420,537,843.7
  投资支付的现金796,999,900539,999,900222,000,0001,118,500,000
  取得子公司及其他营业单位支付的现金0-00
  支付其他与投资活动有关的现金--080,000
  投资活动现金流出小计873,382,080.85604,682,628.27266,143,555.311,539,117,843.7
  投资活动产生的现金流量净额-150,217,872.4-68,895,539.19-92,666,023.25-527,110,249.6
三、筹资活动产生的现金流量:
  吸收投资收到的现金480,000480,000480,000100,000
  其中:子公司吸收少数股东投资收到的现金480,000480,000480,000100,000
  取得借款收到的现金0-030,000,000
  收到其他与筹资活动有关的现金2,214,0002,214,00001,981,058.41
  筹资活动现金流入小计2,694,0002,694,000480,00032,081,058.41
  偿还债务支付的现金30,000,00030,000,00030,000,00057,040,000
  分配股利、利润或偿付利息支付的现金52,851,878.9430,396,853.19289,214.1352,473,757.67
  其中:子公司支付给少数股东的股利、利润--00
  支付其他与筹资活动有关的现金10,340,066.18,337,046.53018,986,342.39
  筹资活动现金流出小计93,191,945.0468,733,899.7230,289,214.13128,500,100.06
  筹资活动产生的现金流量净额-90,497,945.04-66,039,899.72-29,809,214.13-96,419,041.65
四、汇率变动对现金及现金等价物的影响-487,295.89-390,807.3-39,862.028,121.7
五、现金及现金等价物净增加额-96,225,368.38-39,040,330.62-168,774,287.99-225,709,021.9
  加:期初现金及现金等价物余额726,615,036.35726,615,036.35726,615,036.35952,324,058.25
  期末现金及现金等价物余额630,389,667.97687,574,705.73557,840,748.36726,615,036.35
补充资料:
  净利润-55,608,076.33-262,674,724.72
  资产减值准备-3,708,061.03--2,991,776.71
  固定资产和投资性房地产折旧-70,232,741.92-182,439,587.26
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-70,232,741.92-182,439,587.26
  无形资产摊销-6,905,974.6-11,751,275.02
  长期待摊费用摊销-9,908,798.46-12,654,106.09
  处置固定资产、无形资产和其他长期资产的损失--6,305.93-665,892.86
  固定资产报废损失-229,450.91-2,197,794.56
  公允价值变动损失--226,892.6--81,517.67
  财务费用-534,208.34-4,962,804.24
  投资损失--2,342,205.59--14,458,479.33
  递延所得税--17,382,798.1--7,288,565.21
  其中:递延所得税资产减少--11,788,040.4--5,218,375.7
    递延所得税负债增加--5,594,757.7--2,070,189.51
  存货的减少-34,237,850.25--33,597,364.29
  经营性应收项目的减少--29,650,474.1-16,714,442.5
  经营性应付项目的增加--42,018,634.9--67,177,759.79
  其他--1,096,138.72-13,332,761.68
  不涉及现金收支的投资和筹资活动金额其他项目---34,360,271.62
  现金的期末余额-687,574,705.73-726,615,036.35
  减:现金的期初余额-726,615,036.35-952,324,058.25
  现金及现金等价物的净增加额--39,040,330.62--225,709,021.9
公告日期2025-10-292025-08-292025-04-262025-04-19
审计意见(境内)标准无保留意见
TOP↑